Literature DB >> 1541367

[Study on uric acid metabolism in patients with primary aldosteronism].

M Namba1, K Kikuchi, H Komura, S Suzuki, N Satoh, T Ohtomo, T Takada, S Marusaki, O Iimura.   

Abstract

This study was conducted to elucidate renal uric acid metabolism in patients with primary aldosteronism (PA;16 cases) as compared with normotensive subjects (NT;25 cases) and essential hypertensives (EHT;51 cases). All subjects were hospitalized and received a regular diet(Na;120 mEq,K;75 mEq,daily) for more than two weeks, after which renal clearance tests were performed, and serum uric acid(SUA), fractional excretions of uric acid(FEUA), sodium(FENa), and inorganic phosphorus(FEP) were evaluated. Plasma aldosterone concentration(PAC) was measured in 16 patients with PA before treatment and in 8 patients after adrenalectomy. SUA was lower in PA than in either NT or EHT, and this lowering was more obvious in male subjects. In NT, PA and EHT, FEUA, an index of renal excretion of uric acid, correlated negatively with SUA and positively with FENa and FEP, which reflected sodium reabsorption at the renal total tubules and proximal tubules, respectively. Although FENa was nearly the same in all the three groups, FEUA and FEP were significantly higher in PA than in EHT or NT. However, no significant correlation was found between PAC and SUA or FEUA in PA. In PA a significant increase of SUA, and decreases of FEUA and FEP were observed after the removal of adenoma compared to before the surgery. These results suggest that uric acid transport might be closely related to sodium transport in the renal tubules, particularly at the proximal site, and also lead to the conclusion that the lower SUA in PA resulted from the suppression of reabsorption and/or an enhancement of secretion of uric acid in the proximal tubules, being related to the so-called escape phenomenon.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541367     DOI: 10.1507/endocrine1927.68.1_51

Source DB:  PubMed          Journal:  Nihon Naibunpi Gakkai Zasshi        ISSN: 0029-0661


  5 in total

1.  Development and validation of a novel diagnostic nomogram model to predict primary aldosteronism in patients with hypertension.

Authors:  Meng-Hui Wang; Nan-Fang Li; Qin Luo; Guo-Liang Wang; Mulalibieke Heizhati; Ling Wang; Lei Wang; Wei-Wei Zhang
Journal:  Endocrine       Date:  2021-05-24       Impact factor: 3.633

2.  A case of insulin edema with inappropriate hyperaldosteronism.

Authors:  G Kalambokis; A Tsatsoulis; G Economou; E V Tsianos
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

3.  Reliability Analysis of a Functional Diagnostic Test for Primary Hyperaldosteronism Based on Data Analysis.

Authors:  Yan Wang; Jun Cai
Journal:  Comput Intell Neurosci       Date:  2022-06-27

4.  Body mass index and contralateral ratio predict outcome following unilateral adrenalectomy in primary aldosteronism.

Authors:  Kanako Bokuda; Midori Yatabe; Yuki Mizuguchi; Michita Niiyama; Yasufumi Seki; Daisuke Watanabe; Junichi Yatabe; Takashi Ando; Satoshi Morimoto; Atsuhiro Ichihara
Journal:  Hypertens Res       Date:  2017-10-05       Impact factor: 3.872

5.  Spironolactone increases serum uric acid levels in patients with chronic kidney disease.

Authors:  S E Cabrera; N C Edwards; R P Steeds; J N Townend; C J Ferro
Journal:  J Hum Hypertens       Date:  2013-07-18       Impact factor: 3.012

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.